, Tracking Stock Market Picks
Enter Symbol:
Keryx Biopharmaceuticals, Inc. (KERX) [hlAlert]

up 4,328.57 %

Keryx Biopharmaceuticals, Inc. (KERX) rated Buy with price target $5 by Brean Murray

Posted on: Monday,  Apr 2, 2012  10:25 AM ET by Brean Murray

Brean Murray rated Buy Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) on 04/02/2012. Previously Brean Murray rated Buy Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) on
03/16/2009., when the stock price was $0.14. Since then, Keryx Biopharmaceuticals, Inc. has gained 4328.57% as of 01/12/2016's recent price of $6.20.
If you would have followed the previous Brean Murray's recommendation on KERX, you would have gained 4328.57% of your investment in 2493 days.

Keryx Biophamaceutical, Inc. uses data discovered through the mapping of the human genome to generate drug candidates that target the regulation of protein kinases. Protein kinases play a key role in the way cells communicate.

Our equity research department is focused on fundamental analysis across the universe of over 200 small/mid cap stocks in our five target sectors. We are committed to providing proprietary action-oriented research to our institutional clients. Small cap growth focus. Our primary area of concentration is growth stocks with market capitalization of $200 million to $5 billion. Global perspective. We are covering U.S. listed stocks for companies domiciled in the U.S., China, Europe and Latin America, with our biggest concentration in the US and China. We were one of the first banks to aggressively expand our research to China and we believe we created one of the premier research franchises in small cap, U.S. listed Chinese companies to complement our strong domestic coverage. Disciplined stock selection. Our research analysts are focused on performing extensive bottoms up due diligence on companies under our coverage by leveraging their industry and management contacts. By combining our bottoms up work with our sector views we seek to generate a consistent flow of high conviction ideas for our clients. Diversified coverage. Our areas of expertise include technology, consumer, healthcare, resources and China small cap. We provide our clients with company-specific as well as sector-specific research across our target sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/2/2012 10:25 AM Buy
1.71 5.00
as of 8/27/2015
1 Week down  -0.95 %
1 Month down  -38.36 %
3 Months down  -39.33 %
1 YTD down  -52.12 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/16/2009 9:25 AM Buy
0.14 3.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy